-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Adjusts Price Target on Quest Diagnostics to $158 From $146, Maintains Equalweight Rating

Morgan Stanley Adjusts Price Target on Quest Diagnostics to $158 From $146, Maintains Equalweight Rating

MT Newswires · 01/06/2023 06:29